SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jyothy Laboratories trades jubilantly on plan to merge Henkel India with itself

14 Jun 2012 Evaluate

Jyothy Laboratories is currently trading at Rs. 236.50, up by 6.85 points or 2.98% from its previous closing of Rs. 229.65 on the BSE.

The scrip opened at Rs. 234.35 and has touched a high and low of Rs. 239.50 and Rs. 233.45 respectively. So far 34632 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 252.00 on 20-Jul-2011 and a 52 week low of Rs. 125.00 on 08-Nov-2011.

Last one week high and low of the scrip stood at Rs. 239.50 and Rs. 213.50 respectively. The current market cap of the company is Rs. 1908.96 crore.

The promoters holding in the company stood at 65.25 % while Institutions and Non-Institutions held 26.44 % and 8.31 % respectively.

Jyothy Laboratories is planning to merge Henkel India with itself. In this regard, the company’s board will meet on June 15 to consider a proposal for amalgamation of Henkel India with the company and the valuation report for the purpose of exchange ratio.

Recently, Jyothy Laboratories has recommended the issue of bonus shares in the ratio of one share for every equity share held subject to the approval of shareholders. Last year, Henkel India became a subsidiary of Jyothy Laboratories consequent to the selling of 50.87 percent stake in Henkal India held by Henkel AG & Co. of Germany.

Jyothy Laboratories reported a surge of 21.83% in its net profit to Rs 27.90 crore for the fourth quarter ended March 31, 2012 as compared to Rs 22.9 crore in the same period of previous fiscal. The net sales of the company rose to Rs 218.9 crore for the fourth quarter ended March 31, 2012, against Rs 155.9 crore in the same period of previous fiscal, up by 40.41%.

Jyothy Labs Share Price

238.45 9.40 (4.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2241.10
Godrej Consumer Prod 1108.20
Dabur India 442.10
Colgate Palmol. (I) 2106.20
P&G Hygiene 10006.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×